Zimmer Biomet Announces Second Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Zimmer Biomet's (ZBH) strong second quarter tarnished by high expectations
August 1, 2023 12:13 PM EDTShares of medical technology company Zimmer Biomet (NYSE: ZBH) declined after it reported results for the second quarter of 2023. Revenue, earnings per share, and guidance all topped published consensus figures but they were still not enough to meet elevated expectations on Wall Street.
Zimmer Biomet reported second quarter EPS of 1.82, a... More
